Entera Bio Ltd. (ENTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Entera Bio Ltd.

    NASDAQ: ENTX · Real-Time Price · USD
    2.06
    -0.10 (-4.63%)
    At close: Sep 05, 2025, 3:59 PM
    2.05
    -0.49%
    After-hours: Sep 05, 2025, 07:51 PM EDT

    Entera Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 181K n/a 134K 571K
    Cost of Revenue
    		 172K 56K 101K 373K
    Gross Profit
    		 9K -56K 33K 198K
    Operating Income
    		 -9.59M -8.89M -13.02M -12.22M
    Interest Income
    		 58K 31K 83K n/a
    Pretax Income
    		 -9.53M -8.86M -12.93M -12.25M
    Net Income
    		 -9.54M -8.89M -13.07M -12.19M
    Selling & General & Admin
    		 5.09M 4.43M 7.25M 5.69M
    Research & Development
    		 4.5M 4.51M 5.85M 6.77M
    Other Expenses
    		 n/a n/a -51K -46K
    Operating Expenses
    		 9.59M 8.88M 13.05M 12.41M
    Interest Expense
    		 n/a n/a n/a 29K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 9.77M 8.94M 13.15M 12.79M
    Income Tax Expense
    		 14K 29K 137K -59K
    Shares Outstanding (Basic)
    		 37.65M 29.01M 28.81M 26.13M
    Shares Outstanding (Diluted)
    		 37.65M 29.01M 28.81M 26.13M
    EPS (Basic)
    		 -0.25 -0.31 -0.45 -0.47
    EPS (Diluted)
    		 -0.25 -0.31 -0.45 -0.47
    EBITDA
    		 -9.54M -8.8M -12.87M -12.16M
    EBIT
    		 -9.59M -8.86M -13.02M -12.22M
    Depreciation & Amortization
    		 46K 56K 64K 53K

    Add to Watchlist